2012 SEMDSA Guideline for type 2 diabetes mellitus
... aSevere decompensation includes any of: FPG > 15mmol/L, HbA1C > 11%, marked polyuria & polydipsia, weight loss > 5% or ketoacidosis. Refer the patient for specialist care (Step 4). bRefer to Table I for expected HbA1C reductions. cRefer to text dIf at diagnosis, the patient’s HbA1C is >9% without fe ...
... aSevere decompensation includes any of: FPG > 15mmol/L, HbA1C > 11%, marked polyuria & polydipsia, weight loss > 5% or ketoacidosis. Refer the patient for specialist care (Step 4). bRefer to Table I for expected HbA1C reductions. cRefer to text dIf at diagnosis, the patient’s HbA1C is >9% without fe ...
Phase 1: Target Blood Glucose 150 to 200 mg/dl - Providence
... 10. Diet: 1800 ADA Diabetic Diet starts with any PO intake. When need to advance diet exists, may begin with FULL liquids or SUGARFREE clear liquids and advance as tolerated. Patient may take oral or enternal nutrition at any time in conjunction with this protocol. 11. Prandial Subcutaneous Rapid-Ac ...
... 10. Diet: 1800 ADA Diabetic Diet starts with any PO intake. When need to advance diet exists, may begin with FULL liquids or SUGARFREE clear liquids and advance as tolerated. Patient may take oral or enternal nutrition at any time in conjunction with this protocol. 11. Prandial Subcutaneous Rapid-Ac ...
Type 2 diabetes and hypertension - COMDIS-HSD
... Management of Adolescent-Adult Illness (IMAI), to manage diseases that are not within the scope of this guide. It provides a systematic approach to monitoring of patients with these diseases and preventing and identifying complications. It clearly indicates when to refer patients to a district hospi ...
... Management of Adolescent-Adult Illness (IMAI), to manage diseases that are not within the scope of this guide. It provides a systematic approach to monitoring of patients with these diseases and preventing and identifying complications. It clearly indicates when to refer patients to a district hospi ...
T Diabetic Ketoacidosis in Infants, Children, and Adolescents
... Fluid and electrolyte therapy DKA is characterized by severe depletion of water and electrolytes from both the intracellular fluid and extracellular fluid (ECF) compartments; the range of losses is shown in Table 2. Despite their dehydration, patients continue to have considerable urine output until ...
... Fluid and electrolyte therapy DKA is characterized by severe depletion of water and electrolytes from both the intracellular fluid and extracellular fluid (ECF) compartments; the range of losses is shown in Table 2. Despite their dehydration, patients continue to have considerable urine output until ...
Defining Diabetes - Healing Our Communities
... Diabetes is a disease in which your body is not able to take the sugar from your blood and put it into your cells. That’s why your doctors are always worrying about your “high blood sugar.” Sugar needs to be in the cells because sugar is fuel or rather the gasoline that the cells need to make your b ...
... Diabetes is a disease in which your body is not able to take the sugar from your blood and put it into your cells. That’s why your doctors are always worrying about your “high blood sugar.” Sugar needs to be in the cells because sugar is fuel or rather the gasoline that the cells need to make your b ...
Metabolic syndrome English (power point)
... Oral glucose tolerance test (OGTT) • The glucose tolerance test is a medical test in which glucose (also known as dextrose) is given orally and blood samples for plasma glucose are taken afterward to determine how quickly it is cleared from the blood, • The test is usually used to test for insulin ...
... Oral glucose tolerance test (OGTT) • The glucose tolerance test is a medical test in which glucose (also known as dextrose) is given orally and blood samples for plasma glucose are taken afterward to determine how quickly it is cleared from the blood, • The test is usually used to test for insulin ...
SGLT2 - 埼玉医科大学総合医療センター 内分泌・糖尿病内科
... respectively, whereas tofogliflozin, luseogliflozin and ipragliflozin have been approved in Japan. Other SGLT2 inhibitors (remogliflozin, ertugliflozin and sotagliflozin) are under development. ...
... respectively, whereas tofogliflozin, luseogliflozin and ipragliflozin have been approved in Japan. Other SGLT2 inhibitors (remogliflozin, ertugliflozin and sotagliflozin) are under development. ...
Operational research techniques in medical treatment and diagnosis
... pathology is measured or categorised in suitable classes. Instead, many types of medical treatments and diagnoses would lend themselves well to representing them by suitable dynamic systems, so that not only the state but the change of states are monitored explicitly. Instead in many cases these dyn ...
... pathology is measured or categorised in suitable classes. Instead, many types of medical treatments and diagnoses would lend themselves well to representing them by suitable dynamic systems, so that not only the state but the change of states are monitored explicitly. Instead in many cases these dyn ...
Dental Care and Treatment of Children with Diabetes Mellitus
... many years because the hyperglycemia develops gradually and in the earlier stages is not severe enough to produce the classic symptoms of diabetes; however, such patients are at increased risk of developing macrovascular and microvascular complications. The classic symptoms of polyuria, thirst, recu ...
... many years because the hyperglycemia develops gradually and in the earlier stages is not severe enough to produce the classic symptoms of diabetes; however, such patients are at increased risk of developing macrovascular and microvascular complications. The classic symptoms of polyuria, thirst, recu ...
Peritoneal Dialysis Solution:
... The term “glucose-specific” applies to monitors or test strips that are not affected by the presence of maltose or certain other sugars. Because EXTRANEAL (icodextrin) peritoneal dialysis solution results in elevated blood levels of maltose, only glucose-specific monitors and test strips should be u ...
... The term “glucose-specific” applies to monitors or test strips that are not affected by the presence of maltose or certain other sugars. Because EXTRANEAL (icodextrin) peritoneal dialysis solution results in elevated blood levels of maltose, only glucose-specific monitors and test strips should be u ...
Glucerna 1.2 Cal Monograph
... of the gastrointestinal tract than simpler forms of carbohydrates (Figure 2.1). Including slowly digested carbohydrates in the diet permits individuals with diabetes to absorb glucose more evenly than when simple carbohydrates are consumed or when the carbohydrate source is rapidly digested and abso ...
... of the gastrointestinal tract than simpler forms of carbohydrates (Figure 2.1). Including slowly digested carbohydrates in the diet permits individuals with diabetes to absorb glucose more evenly than when simple carbohydrates are consumed or when the carbohydrate source is rapidly digested and abso ...
The association between serum lipid ratios and insulin - DUO
... to diagnose IGT was 48.6% and 82.6%, while the positive predictive value was 50.7% and negative predictive value was found 81.1%. Data analysis at baseline showed no difference between mean ages and gender of combined IFG-IGT and isolated IGT group, however waist to hip ratio was significantly highe ...
... to diagnose IGT was 48.6% and 82.6%, while the positive predictive value was 50.7% and negative predictive value was found 81.1%. Data analysis at baseline showed no difference between mean ages and gender of combined IFG-IGT and isolated IGT group, however waist to hip ratio was significantly highe ...
Glycemic Management of Type 2 Diabetes: An Emerging Strategy
... is common, complex, and as treated presently, leads to severe medical consequences. In type 1 diabetes, hyperglycemia is the leading cause of harm. In type 2 diabetes, despite a well-documented contribution from other abnormalities that together have come to be known as the metabolic syndrome, hyper ...
... is common, complex, and as treated presently, leads to severe medical consequences. In type 1 diabetes, hyperglycemia is the leading cause of harm. In type 2 diabetes, despite a well-documented contribution from other abnormalities that together have come to be known as the metabolic syndrome, hyper ...
Guidelines for Pre-diabetes Diagnosis and Management
... How is pre-diabetes diagnosed? Categories of increased risk for diabetes Impaired Fasting Glucose [IFG]: Fasting Plasma Gluocse 100–125 mg/dl Impaired Glucose Tolerance [IGT]: 2-hour Plasma Glucose on the 75-g Oral Glucose Tolerance Test 140–199 mg/dl A1C 5.7 – 6.4% For all three tests, risk is con ...
... How is pre-diabetes diagnosed? Categories of increased risk for diabetes Impaired Fasting Glucose [IFG]: Fasting Plasma Gluocse 100–125 mg/dl Impaired Glucose Tolerance [IGT]: 2-hour Plasma Glucose on the 75-g Oral Glucose Tolerance Test 140–199 mg/dl A1C 5.7 – 6.4% For all three tests, risk is con ...
The Expanding Role of Aerosols in Systemic Drug Delivery, Gene
... of insulin as an aerosol to treat diabetes. In the United States, an estimated 16 million people have diabetes mellitus. The majority of these have non-insulin-dependent diabetes mellitus, or type 2 diabetes. To treat their diabetes, type 2 diabetics can change their diet, exercise, and/or take oral ...
... of insulin as an aerosol to treat diabetes. In the United States, an estimated 16 million people have diabetes mellitus. The majority of these have non-insulin-dependent diabetes mellitus, or type 2 diabetes. To treat their diabetes, type 2 diabetics can change their diet, exercise, and/or take oral ...
STANDARD TREATMENT GUIDELINES ENDOCRINOLOGY
... Once in a year for all Type -2 diabetics from the time of diagnosis*.In Type -1 once every year from 4-5 years after diagnosis or at the age of 10 years.More frequent exams are needed in advanced retinopathy *Frequency of these tests can be more whereever indicated ...
... Once in a year for all Type -2 diabetics from the time of diagnosis*.In Type -1 once every year from 4-5 years after diagnosis or at the age of 10 years.More frequent exams are needed in advanced retinopathy *Frequency of these tests can be more whereever indicated ...
View Full Page PDF - The Royal College of Psychiatrists
... Despite its unique benefits, it can also cause severe side-effects, most notably agranulocytosis, and as a consequence its use is strictly regulated in most countries and requires routine monitoring of full blood count.1 Although many atypical antipsychotics, such as quetiapine or olanzapine, can in ...
... Despite its unique benefits, it can also cause severe side-effects, most notably agranulocytosis, and as a consequence its use is strictly regulated in most countries and requires routine monitoring of full blood count.1 Although many atypical antipsychotics, such as quetiapine or olanzapine, can in ...
HIV’s Vpr protein - Lake Forest College
... • Vitamin E is an anti-oxidant • Thus, oxidative stress calcium levels and activates protein degradation. ...
... • Vitamin E is an anti-oxidant • Thus, oxidative stress calcium levels and activates protein degradation. ...
LWW PPT Slide Template Master
... • Hypoglycemia can occur during and after exercise • Hyperglycemia can occur in type 1 diabetics with poor blood glucose control • Those with neuropathy of legs and feet might have gait or balance problems; avoid quick changes • Participate in activity at the same time each day ...
... • Hypoglycemia can occur during and after exercise • Hyperglycemia can occur in type 1 diabetics with poor blood glucose control • Those with neuropathy of legs and feet might have gait or balance problems; avoid quick changes • Participate in activity at the same time each day ...
Chapter 11: Care of the Patient with an Endocrine Disorder
... a. It is a substitute for insulin and acts by directly stimulating glucose uptake into the cell. b. It does not cause the hypoglycemic reactions that may occur with insulin use. c. It is thought to stimulate insulin production and increase sensitivity to insulin at receptor sites. d. It lowers blood ...
... a. It is a substitute for insulin and acts by directly stimulating glucose uptake into the cell. b. It does not cause the hypoglycemic reactions that may occur with insulin use. c. It is thought to stimulate insulin production and increase sensitivity to insulin at receptor sites. d. It lowers blood ...
06 Frayling
... clinical example of this is the macrosomic children born to mothers with diabetes in pregnancy. Pedersen proposed that this macrosomia did not result from a direct increase in the transfer of nutrients, but was mediated indirectly by increased fetal insulin secretion in response to fetal sensing of ...
... clinical example of this is the macrosomic children born to mothers with diabetes in pregnancy. Pedersen proposed that this macrosomia did not result from a direct increase in the transfer of nutrients, but was mediated indirectly by increased fetal insulin secretion in response to fetal sensing of ...
Case Study: Cognitive Impairment, Depression, and Severe
... for people suffering from depression and to one of the clinic’s diabetes support groups. For additional social connection, he was encouraged to pursue his interest in photography. Steve followed through on all recommendations. He has not had a severe hypoglycemic episode during the past 7 months. Hi ...
... for people suffering from depression and to one of the clinic’s diabetes support groups. For additional social connection, he was encouraged to pursue his interest in photography. Steve followed through on all recommendations. He has not had a severe hypoglycemic episode during the past 7 months. Hi ...
Artificial pancreas
The artificial pancreas is a technology in development to help people with diabetes automatically control their blood glucose level by providing the substitute endocrine functionality of a healthy pancreas.There are several important exocrine (digestive) and endocrine (hormonal) functions of the pancreas, but it is the lack of insulin production which is the motivation to develop a substitute. While the current state of insulin replacement therapy is appreciated for its life-saving capability, the task of manually managing the blood sugar level with insulin alone is arduous and inadequate.The goal of the artificial pancreas is two-fold:to improve insulin replacement therapy until glycemic control is practically normal as evident by the avoidance of the complications of hyperglycemia, and to ease the burden of therapy for the insulin-dependent.Different approaches under consideration include: the medical equipment approach—using an insulin pump under closed loop control using real-time data from a continuous blood glucose sensor. the bioengineering approach—the development of a bio-artificial pancreas consisting of a biocompatible sheet of encapsulated beta cells. When surgically implanted, the islet sheet will behave as the endocrine pancreas and will be viable for years. the gene therapy approach—the therapeutic infection of a diabetic person by a genetically engineered virus which causes a DNA change of intestinal cells to become insulin-producing cells.